These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23344680)

  • 1. Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire.
    Winkler G; Hídvégi T; Vándorfi G; Balogh S; Jermendy G
    Med Sci Monit; 2013 Jan; 19():67-72. PubMed ID: 23344680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk-stratified screening for diabetes in adults: results of the first investigation in Hungary].
    Winkler G; Hidvégi T; Vándorfi G; Jermendy G
    Orv Hetil; 2010 Apr; 151(17):691-6. PubMed ID: 20388612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
    Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
    Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for people with abnormal glucose metabolism in the European DE-PLAN project.
    Cos FX; Barengo NC; Costa B; Mundet-Tudurí X; Lindström J; Tuomilehto JO;
    Diabetes Res Clin Pract; 2015 Jul; 109(1):149-56. PubMed ID: 25931281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian Diabetes Screening Study: impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Welborn TA; Reid CM; Marriott G
    Metabolism; 1997 Dec; 46(12 Suppl 1):35-9. PubMed ID: 9439557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trøndelag Diabetes Study.
    Midthjell K; Bjørndal A; Holmen J; Krüger O; Bjartveit K
    Scand J Prim Health Care; 1995 Sep; 13(3):229-35. PubMed ID: 7481177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes primary prevention program: New insights from data analysis of recruitment period.
    Gagliardino JJ; Elgart JF; Bourgeois M; Etchegoyen G; Fantuzzi G; Ré M; Ricart JP; García S; Giampieri C; González L; Suárez-Crivaro F; Kronsbein P; Angelini JM; Martínez C; Martínez J; Ricart A; Spinedi E
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28843031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
    Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
    BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of impaired glucose tolerance and undiagnosed type 2 diabetes in UK South Asians: an effective screening strategy.
    Hanif MW; Valsamakis G; Dixon A; Boutsiadis A; Jones AF; Barnett AH; Kumar S
    Diabetes Obes Metab; 2008 Sep; 10(9):755-62. PubMed ID: 17941866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
    Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
    Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria.
    Amoah AG
    Acta Diabetol; 2002 Apr; 39(1):7-13. PubMed ID: 12043940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance.
    Liu M; Pan C; Jin M
    Diabetes Technol Ther; 2011 May; 13(5):501-7. PubMed ID: 21406016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk-stratified screening for diabetes in adolescents: results of the first investigation in Hungary].
    Barkai L; Madácsy L
    Orv Hetil; 2010 Oct; 151(42):1742-7. PubMed ID: 20889442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irish diabetes detection programme in general practice.
    Smith SM; Holohan J; McAuliffe A; Firth RG
    Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.